U.S. Chemicals Stock News

Ultra Clean Holdings recently reported first-quarter 2026 results, with revenue rising to US$533.7 million while posting a net loss of US$17.9 million, and concurrently announced the upcoming retirement of CFO Sheri Savage alongside a change in board chair later this month. The company also issued second-quarter guidance calling for higher revenue and a return to GAAP profitability and disclosed new insider trading plans and a Form 144 filing, adding fresh context to its capital structure...

Immunome has submitted a New Drug Application to the FDA for varegacestat, an oral once-daily gamma secretase inhibitor for adults with desmoid tumors, backed by a global Phase 3 RINGSIDE trial that met its primary and key secondary endpoints. A key insight is that RINGSIDE is the largest randomized study conducted in this rare tumor type, with data selected for oral presentation at the 2026 ASCO Annual Meeting, highlighting the clinical community’s interest in varegacestat’s profile. We’ll...

Recent performance snapshot LGI Homes (LGIH) has moved sharply in recent months, with the stock showing a one month gain of 17.7%, a past 3 months decline of 16.7%, and a 1 year total return decline of 19.8%. See our latest analysis for LGI Homes. At a share price of $44.88, LGI Homes has seen momentum fade recently, with a 1 day share price decline of 7.5% following a 30 day share price gain of 17.7%. The 1 year total shareholder return remains down 19.8%, which points to a stock still...

Trevi Therapeutics recently announced plans to present detailed Phase 2b CORAL trial results and additional nalbuphine ER data for IPF-related chronic cough at the ATS 2026 International Conference in Orlando on May 18, 2026. Alongside upcoming Q1 2026 results and a proposal to double authorized common shares, these scientific disclosures highlight how clinical and corporate actions may shape Trevi’s future options for funding and advancing Haduvio. We’ll now examine how the upcoming Phase...

Stock performance snapshot and recent context PTC Therapeutics (PTCT) has drawn investor attention after recent trading, with the stock last closing at $65.49. The company operates in the rare disease biopharma space, with products spanning Duchenne muscular dystrophy and spinal muscular atrophy. See our latest analysis for PTC Therapeutics. Recent trading has been choppy, with a 1-day share price return of 0.52% compared with a 90-day share price return of 12.48% and a 1-year total...

Context for First Horizon stock First Horizon (FHN) has drawn fresh attention after a recent move in its share price, with the stock closing at US$24.63 and showing mixed returns over the past month and past 3 months. See our latest analysis for First Horizon. For context, this recent pullback follows a 6.3% 1 month share price return, while the stock’s 1 year and 3 year total shareholder returns of 34.5% and over 150% point to momentum that has built over time rather than faded. If First...

In the first quarter ended March 31, 2026, Essential Properties Realty Trust, Inc. reported revenue of US$158.8 million and net income of US$59.79 million, both higher than a year earlier, while basic and diluted EPS from continuing operations edged slightly lower to US$0.28. The combination of rising revenue and net income alongside nearly full occupancy and disciplined, low-leverage growth has reinforced Essential Properties Realty Trust’s reputation for resilient cash flows in the triple...

IAC Inc. has reported first-quarter 2026 results, with sales of US$422.89 million versus US$481.69 million a year earlier and a net loss of US$71.88 million compared with US$216.81 million, alongside the closure of long-running Ask.com and continued portfolio reshaping including the completed Angi spin-off. Together with the rebrand of Dotdash Meredith as People Inc. and ongoing cost-saving and asset-divestment efforts, these moves signal IAC’s push to concentrate on human-created premium...

Event overview and recent stock context Agios Pharmaceuticals (AGIO) has drawn attention after a recent share price pullback, with the stock down about 22% over the past month and modestly negative over the past 3 months. See our latest analysis for Agios Pharmaceuticals. That recent 22% one month share price pullback comes after a relatively flat 90 day share price return of about 1% decline and a modestly positive year to date share price return of 1.4%. At the same time, the 1 year total...

OGE Energy (OGE) stock is back in focus after the company reported softer first quarter earnings while confirming long term Electric Service Agreements to power multiple Google data centers in Oklahoma using new solar backed capacity. See our latest analysis for OGE Energy. Despite the softer quarter, the stock has held firm, with a 90 day share price return of 10.46% and an 11.57% year to date share price return. The 5 year total shareholder return of 74.36% points to momentum that has built...

USA Compression Partners (USAC) heads into its Q1 2026 earnings release with increased revenue and earnings estimates for 2026 and 2027 in the past 3 months, following a prior quarter that missed expectations. See our latest analysis for USA Compression Partners. At a share price of $26.95, USA Compression Partners has seen a 13.28% year to date share price return, supported by a 5.56% 90 day gain. The 5 year total shareholder return of 193.40% indicates strong long term compounding despite...

What Eagle Materials' Recent Moves Mean For Shareholders Eagle Materials (EXP) has drawn fresh attention after a recent pullback left the stock with a negative 1 day and past week return, despite a gain over the past month. See our latest analysis for Eagle Materials. The recent 1 day and 7 day share price declines sit against an 8.95% 1 month share price return. The 1 year total shareholder return of a 12.40% decline contrasts with a 5 year total shareholder return of 41.24%, suggesting...

Napco Security Technologies (NSSC) is back in focus after reporting fiscal Q3 2026 results that combined higher revenue and record adjusted EBITDA with a GAAP net loss tied to a litigation settlement. See our latest analysis for Napco Security Technologies. The sharp 15.2% 1 day share price decline and 14.1% 7 day share price return, both negative, suggest investors rapidly adjusted expectations after the Q3 litigation driven loss and dividend announcement. However, the 1 year total...

Eve Holding, Inc. has reported first quarter 2026 results, recording a net loss of US$68.81 million, higher than the US$48.78 million loss in the same period last year. This widening loss underlines the financial strain of Eve’s ongoing eVTOL development phase and raises fresh questions about how its cash resources will support the path to commercialization. We’ll now explore how this larger quarterly net loss may influence Eve Holding’s investment narrative built around future urban air...

Schrödinger, Inc. recently reported its Q1 2026 results after the market close on May 5, 2026, and held its earnings call the same day, following earlier announcements that management would also appear at major May healthcare investor conferences hosted by BofA Securities and RBC. These events highlight Schrödinger’s efforts to spotlight its AI-enabled computational platform and growing hosted software model to a wider base of investors and potential users. We’ll now examine how the upcoming...

Janus Henderson Group (NYSE:JHG) stock is in focus after recent performance data showed a total return of 7.3% over the past 3 months and a 1-year total return above 50%. See our latest analysis for Janus Henderson Group. The current share price of $51.64 comes after a 7.3% three-month share price return. The 1-year total shareholder return above 50% indicates sustained momentum rather than a short-term spike. If you are looking beyond Janus Henderson Group and want more ideas with strong...

What recent price moves suggest about interest in SOLV Energy SOLV Energy (MWH) has drawn fresh attention after a sharp move in its stock price, with a 4.6% gain over the past day, 11.9% over the past week, and about 43% over the past month. This short term momentum comes alongside reported annual revenue of about $2.49b and net income of $149.2m. This has prompted some investors to reassess how the stock’s recent run lines up with its fundamentals and value score of 2. See our latest...

Innoviva’s Shelf Registration and What It Could Mean for Shareholders Innoviva (INVA) has filed a shelf registration to potentially offer up to US$207.99 million of common stock, covering 9,000,000 shares in an ESOP related transaction that could influence future valuation. See our latest analysis for Innoviva. Against the backdrop of this shelf registration and a fresh equity incentive plan, Innoviva’s recent share price return has been mixed in the very short term, but supported by stronger...

In late April 2026, Schneider National, Inc. reported first‑quarter results showing mostly flat revenue at US$1,398.5 million and lower net income of US$20.4 million year on year, while also completing a US$5.21 million share repurchase, affirming a US$0.10 quarterly dividend, and updating its bylaws to strengthen the role of the lead independent director in board leadership and succession. An interesting angle is that Schneider paired an earnings-per-share beat relative to analyst...

Recent commentary around Edgewell Personal Care (EPC) has focused on weaker organic revenue, falling productivity and lower operating margins, alongside a high net-debt-to-EBITDA ratio that has put potential dilution risk on investor radar. See our latest analysis for Edgewell Personal Care. At a share price of $21.56, Edgewell Personal Care has seen a 1 month share price return of 2.76% and a year to date share price return of 27.88%. However, the 1 year total shareholder return of 27.66%...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Recent trading performance and business mix Baldwin Insurance Group (BWIN) has been under pressure, with the stock showing a 46.0% negative total return over the past year and a 7.6% decline year to date, despite a 7.2% gain in the past 3 months. At a last close of US$21.97 and a market value of about US$3.2b, the company operates as an independent insurance distribution platform in the United States, spanning advisory, underwriting and mainstreet-focused solutions. See our latest analysis...

Earnings jump draws fresh focus to Equitable Holdings stock Equitable Holdings (EQH) just posted first quarter results that show net income of US$621 million compared with US$63 million a year earlier, while revenue for the quarter was US$4.23 billion versus US$4.58 billion. See our latest analysis for Equitable Holdings. At a share price of US$41.49, Equitable Holdings has a 30 day share price return of 9.79%, while its 1 year total shareholder return of 15.58% decline contrasts with an...

Q1 earnings and buyback completion put Mueller Industries in focus Mueller Industries (MLI) is back on investors’ radar after first quarter 2026 results showed higher sales, net income, and earnings per share compared with a year earlier, alongside the completion of a long running share repurchase program. See our latest analysis for Mueller Industries. The earnings beat and completion of a long running buyback have come after a 1 month share price return of 18.18% and a 1 year total...